<SEC-DOCUMENT>0001104659-25-110340.txt : 20251112
<SEC-HEADER>0001104659-25-110340.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251112160523
ACCESSION NUMBER:		0001104659-25-110340
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251112

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DarioHealth Corp.
		CENTRAL INDEX KEY:			0001533998
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				452973162
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88306
		FILM NUMBER:		251472599

	BUSINESS ADDRESS:	
		STREET 1:		322 W 57TH ST. #33B
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		972-4-770-6377

	MAIL ADDRESS:	
		STREET 1:		322 W 57TH ST. #33B
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LabStyle Innovations Corp.
		DATE OF NAME CHANGE:	20111101

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tasso Partners, LLC
		CENTRAL INDEX KEY:			0001965743
		ORGANIZATION NAME:           	
		EIN:				862809628
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		P.O. BOX 6194
		CITY:			FAIR HAVEN
		STATE:			NJ
		ZIP:			07704
		BUSINESS PHONE:		347-986-0729

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 6194
		CITY:			FAIR HAVEN
		STATE:			NJ
		ZIP:			07704
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Tasso Partners, LLC -->
          <cik>0001965743</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001533998</issuerCik>
        <issuerName>DarioHealth Corp.</issuerName>
        <issuerCusip>23725P209</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>322 W 57TH ST.</com:street1>
          <com:street2>#33B</com:street2>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10019</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Tasso Partners, LLC</reportingPersonName>
      <memberGroup>a</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>676141.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>676141.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>676141.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.99</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Tasso Partners, LLC owns the DarioHealth Corp. (the "Issuer") shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC. (2) Consists of (i) 612,558 shares of common stock held by the Reporting Person, and (ii) pre-funded warrants exercisable into 1,113,078 shares of common stock, which contain a contractually stipulated 9.99% ownership restriction and which are beneficially owned by Dana Carrera, which is the trustee of GCL Family Trust (the "Trust"), and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) The percentage ownership was calculated based on a denominator which is the sum of 6,768,184 Common Stock outstanding as of the filing date of this report. All information included herein relating to shares or price per share reflects the 1-for-20 reverse split effected by the Issuer on August 28, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Dana Carrera</reportingPersonName>
      <memberGroup>a</memberGroup>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>6250.00</soleVotingPower>
        <sharedVotingPower>669891.00</sharedVotingPower>
        <soleDispositivePower>6250.00</soleDispositivePower>
        <sharedDispositivePower>669891.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>676141.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.99</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Tasso Partners, LLC owns the DarioHealth Corp. (the "Issuer") shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera controls Tasso Capital, LLC. (2) Shared voting and dispositive power consists of (i) 612,558 shares of Common Stock held by the Reporting Person, and (ii) pre-funded warrants exercisable into 1,113,087 shares of common stock which contain a contractually stipulated 9.99% ownership restriction and, which are beneficially owned by Dana Carrera, which is the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) Sole voting and dispositive power consists of 6,250 shares of Common Stock owned by the Trust, which are beneficially owned by Dana Carrera, the trustee of the Trust. (4) Aggregate amount beneficially owned consists of (i) 612,558 shares of Common Stock held by the Reporting Person, and (iii) pre-funded warrants exercisable into 1,113,087 shares of common stock which contain a contractually stipulated 9.99% ownership restriction and, which are beneficially owned by Dana Carrera, the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (5) The percentage ownership was calculated based on a denominator which is the sum of 6,768,184 Common Stock outstanding as of the filing date of this report. All information included herein relating to shares or price per share reflects the 1-for-20 reverse split effected by the Issuer on August 28, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>DarioHealth Corp.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>322 W 57TH ST. #33B NEW YORK, NY, 10019</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed on behalf of: (1) Tasso Partners, LLC (2) Dana Carrera The foregoing persons are hereinafter collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business address of each of the Reporting Persons is: P.O. Box 503 Rumson, NJ 07760</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Citizenship: Tasso Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dana Carrera is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Tasso Partners, LLC - 676,142 shares of common stock Dana Carrera - 676,142 shares of common stock</amountBeneficiallyOwned>
        <classPercent>Tasso Partners, LLC - 9.99% Dana Carrera - 9.99%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Tasso Partners, LLC - 0 Dana Carrera - 6,250</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Tasso Partners, LLC - 676,141 Dana Carrera - 669,891</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Tasso Partners, LLC - 0 Dana Carrera - 6,250</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Tasso Partners, LLC - 676,141 Dana Carrera - 669,891</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>N</notApplicableFlag>
        <identificationAndClassificationOfGroupMembers>Tasso Partners, LLC owns the Issuer shares; Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Carrera is the trustee of the Trust and controls Tasso Capital, LLC.</identificationAndClassificationOfGroupMembers>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Tasso Partners, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dana Carrera</signature>
        <title>Dana Carrera/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC</title>
        <date>11/12/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Dana Carrera</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dana Carrera</signature>
        <title>Dana Carrera</title>
        <date>11/12/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
